IL-7 treatment shows promise in reducing lethal secondary infections in critically ill COVID-19 patients

A new study published in JCI Insight suggests that interleukin-7 (IL-7), a key immune-boosting cytokine, may help critically ill COVID-19 patients by reducing life-threatening secondary infections. Led by Richard S. Hotchkiss, MD, professor of anesthesiology, medicine, surgery, and developmental biology at WashU Medicine, the study highlights IL-7’s ability to enhance immune recovery without triggering harmful inflammation.
Read More

Preventable pediatric cancer mortality surges in areas of armed conflict, exceeding rates in non-conflict regions

More than half of all pediatric cancer deaths worldwide occur in regions of armed conflict, according to a new study led by investigators from St. Jude Children’s Research Hospital, Duke University and other collaborators. The study demonstrated that pediatric cancer diagnoses and mortality are significantly impacted in areas of armed conflict and documented the significant contribution these troubled areas make to the global burden of childhood cancer.
Read More

Pregnancy may reduce long COVID risk

Pregnancy may offer some protection from developing long COVID, found a new study led by Weill Cornell Medicine, University of Rochester Medical Center, University of Utah Health and Louisiana Public Health Institute. Previous research has mostly focused on non-pregnant adults affected by long COVID— a condition lasting for months after a person recovers from SARS-CoV-2 infection.
Read More
Top